I appreciate your viewpoint. I hadn't thought about that, but you're probably right. I was just thinking that it would bring home the point and the reminder that the data are real people who have benefited from our miracle molecule.

Hopefully, the presentation will get the attention of those who can get it to the approval stage so that more people can benefit